Kenji Iida

KI

Statistics

Publications

1

Citations

50

H-Index

1

Active since

2021

Affiliations

Kenji Iida is an author at Harvard University specializing in antibody-drug conjugate therapy, targeted therapy, and tyrosine kinase inhibitor therapy.

Publications per year

2021–2021

1

Publications

1